Elucidating the exact pharmacological system of action (MOA) of naturally occurring compounds can be hard. Whilst Tarselli et al. (60) developed the very first de novo synthetic pathway to conolidine and showcased this naturally happening compound properly suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic target https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers